Clene Inc. Other Comprehensive Income (Loss), Tax
Clene Inc. (CLNN) reported Other Comprehensive Income (Loss), Tax of $6.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossTax · last filed 2022-11-07
- Clene Inc. other comprehensive income (loss), tax for the quarter ending 2022-09-30 was $6.00K, a 93.10% decline year-over-year.
- Clene Inc. other comprehensive income (loss), tax for the quarter ending 2022-06-30 was $147.00K, a 140.98% increase year-over-year.
- Clene Inc. other comprehensive income (loss), tax for the quarter ending 2022-03-31 was $0.00.
- Clene Inc. other comprehensive income (loss), tax for the quarter ending 2021-12-31 was -$32.00K.
- Clene Inc. other comprehensive income (loss), tax for fiscal 2021 was $92.00K.
- Clene Inc. other comprehensive income (loss), tax for fiscal 2020 was -$284.00K, a 9566.67% decline from fiscal 2019.
- Clene Inc. other comprehensive income (loss), tax for fiscal 2019 was $3.00K.
| Period end | Other Comprehensive Income (Loss), Tax 3 month | Other Comprehensive Income (Loss), Tax 6 month | Other Comprehensive Income (Loss), Tax 9 month | Other Comprehensive Income (Loss), Tax 12 month |
|---|---|---|---|---|
| 2022-09-30 | $6.00K 10-Q · filed 2022-11-07 | $153.00K derived: sum of 2 quarters · filed 2022-11-07 | $153.00K 10-Q · filed 2022-11-07 | $121.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-06-30 | $147.00K 10-Q · filed 2022-08-15 | $147.00K 10-Q · filed 2022-08-15 | $115.00K derived: sum of 3 quarters · filed 2022-08-15 | $202.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 | -$32.00K derived: sum of 2 quarters · filed 2022-05-09 | $55.00K derived: sum of 3 quarters · filed 2022-11-07 | $116.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-12-31 | -$32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $55.00K derived: sum of 2 quarters · filed 2022-11-07 | $116.00K derived: sum of 3 quarters · filed 2022-11-07 | $92.00K 10-K · filed 2022-03-11 |
| 2021-09-30 | $87.00K 10-Q · filed 2022-11-07 | $148.00K derived: sum of 2 quarters · filed 2022-11-07 | $124.00K 10-Q · filed 2022-11-07 | -$142.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $61.00K 10-Q · filed 2022-08-15 | $37.00K 10-Q · filed 2022-08-15 | -$229.00K derived: sum of 3 quarters · filed 2022-08-15 | -$231.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$24.00K 10-Q · filed 2022-05-09 | -$290.00K derived: sum of 2 quarters · filed 2022-05-09 | -$292.00K derived: sum of 3 quarters · filed 2022-05-09 | -$302.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$266.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$268.00K derived: sum of 2 quarters · filed 2022-03-11 | -$278.00K derived: sum of 3 quarters · filed 2022-03-11 | -$284.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | -$2.00K 10-Q · filed 2021-11-08 | -$12.00K derived: sum of 2 quarters · filed 2021-11-08 | -$18.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | -$10.00K 10-Q · filed 2021-08-09 | -$16.00K 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | -$6.00K 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | $3.00K 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |